Go back to the public home page
Hello .
 U.S. 

  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Norton Rose Fulbright LLP

    ESG – Key regulatory risks for financial services firms in the UK and[...]

  • Rani Therapeutics Holdings Inc.

    Rani Therapeutics Appoints Lisa Rometty to Board of Directors

  • Rani Therapeutics Holdings Inc.

    Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral[...]

More

Healthcare

  • Rani Therapeutics Holdings Inc.

    Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral[...]

  • Rani Therapeutics Holdings Inc.

    Rani Therapeutics to Release Fourth Quarter and Full Year 2021[...]

  • Rani Therapeutics Holdings Inc.

    Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial[...]

More

Glaukos Corporation

05/20/2022 | Press release | Distributed by Public on 05/20/2022 05:01

Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | Glaukos Corporation | News | Health | Medical Technology | Healthcare Equipment and Services | Medical Technology | Company News | Corporate and Financial Calendar | Conference Calls and Webcasts | Financial Services | Investment Services | Manufacturing | Information Technology | Software | Semiconductors and Electronic Components | Public Companies | Medical Supplies and Equipment Companies | New York Stock Exchange (NYSE) | Börse Frankfurt | Börse Düsseldorf | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact